Asher Biotherapeutics
PrivateLast Round
Series C
Apr 16, 2024
Total Funding Raised
$218.15M
Company Overview
AsherBio is a biotechnology company that develops immunotherapy drugs aimed at effectively treating cancer by enhancing the immune system's ability to target cancer cells with precision and minimal side effects, allowing for quicker patient treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asher Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Asher Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 16, 2024 | ||||
| Series B | Sep 1, 2021 | ||||
| Series A | Mar 23, 2021 | ||||
| Accelerator | Aug 19, 2019 |
Key People
Founding team and executive leadership
Asher Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C, Series B |
| RA Capital Management | Series B, Series C |
| Boxer Capital | Series C |
| Invus Opportunities | Series A, Series B |
| Logos Capital | Series B |
| MBC BioLabs | Series A |
| Y Combinator | Series A, Accelerator |
Asher Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Asher Biotherapeutics's valuation, stock price, and market status.
